This inventor holds 1 USPTO granted patent. Top assignee: Hoechst Aktiengesellschaft. Active years: 1978.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1978
Title: Norbert Kothe: Innovator in Pharmaceutical Chemistry
Introduction: Norbert Kothe, based in Kronberg, Taunus, Germany, is a noteworthy inventor in the field of pharmaceutical chemistry. He holds a significant patent that contributes to the development of valuable medications.
Latest Patents: Kothe's notable patent involves 4-Quinazolinyl-guanidines, specifically the (2-Amino-4-quinazolinyl)-guanidines of the defined formula. This patent encompasses their physiologically tolerable acid addition salts, alongside a detailed process for preparing these compounds. Additionally, it highlights their potential use in pharmaceutical preparations and as medicinal products.
Career Highlights: Norbert Kothe is associated with Hoechst Aktiengesellschaft, a prominent company known for its contributions to the pharmaceutical industry. His work there has involved extensive research and innovation that have furthered the development of therapeutic solutions.
Collaborations: Throughout his career, Kothe has collaborated with esteemed colleagues, including Wulf Merkel and Hans G Alpermann. These collaborations have been instrumental in advancing their collective research endeavors.
Conclusion: Norbert Kothe's contributions through his patents and collaborative efforts underscore his role as a pioneer in pharmaceutical chemistry. His innovative work continues to impact the field significantly, paving the way for future advancements in medicinal applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile